World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
52
Citations
9911
World Ranking
4200
National Ranking
1627

P. David Rogers publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where P. David Rogers sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 129 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

P. David Rogers D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where P. David Rogers sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 52 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

P. David Rogers is affiliated with St. Jude Children's Research Hospital in the United States. Their research spans primarily within the field of Medicine, with significant contributions focused on Infectious Diseases, Epidemiology, and Pharmacology.

Their notable recent papers include:

  • Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris, 2020, mBio
  • In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris, 2021, Clinical Microbiology and Infection
  • The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris, 2022, Current Opinion in Microbiology
  • Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance, 2021, Microbiology Spectrum
  • Mechanisms of triazole resistance in Aspergillus fumigatus, 2020, Environmental Microbiology

Their research topics reflect a focus on fungal pathogens and antifungal resistance, with main topics including:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Fungal Biology and Applications
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Fungal and yeast genetics research
  • Infectious Diseases and Mycology
  • Microbial Natural Products and Biosynthesis

P. David Rogers has published frequently in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Antimicrobial Agents and Chemotherapy
  • Clinical Microbiology and Infection
  • mSphere
  • mBio

They have collaborated extensively with several co-authors, including:

  • Jeffrey M. Rybak
  • Christina A. Cuomo
  • Katherine S. Barker
  • Josie E. Parker
  • Laura A. Doorley

The body of work by P. David Rogers addresses mechanisms of antifungal drug resistance with a particular focus on emerging fungal pathogens such as Candida auris. Their work covers molecular genetics, clinical resistance patterns, and pharmacological aspects, contributing to understanding the challenges faced in managing fungal infections.

Best Publications

  • Azole antifungal resistance in Candida albicans and emerging non-albicans Candida Species

    Sarah G. Whaley;Elizabeth L. Berkow;Jeffrey M. Rybak;Andrew T. Nishimoto

  • Mechanisms of Antifungal Drug Resistance

    Leah E. Cowen;Dominique Sanglard;Susan J. Howard;P. David Rogers

  • Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida albicans

    Teresa T. Liu;Robin E. B. Lee;Katherine S. Barker;Richard E. Lee

  • The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.

    Joachim Morschhäuser;Katherine S Barker;Teresa T Liu;Julia Blaß-Warmuth

  • Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains.

    Nico Dunkel;Julia Blaß;P. David Rogers;Joachim Morschhäuser

  • A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.

    Nico Dunkel;Teresa T. Liu;Katherine S. Barker;Ramin Homayouni

  • A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens

    Calvin C Daniels;P David Rogers;Chasity M Shelton

  • Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans

    Stephanie A. Flowers;Brendan Colón;Sarah G. Whaley;Mary A. Schuler

  • Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.

    John-Paul Vermitsky;Kelly D. Earhart;W. Lamar Smith;Ramin Homayouni

  • Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans

    Stephanie A. Flowers;Katherine S. Barker;Elizabeth L. Berkow;Geoffrey Toner

  • Genome-wide Expression Profiling of the Response to Polyene, Pyrimidine, Azole, and Echinocandin Antifungal Agents in Saccharomyces cerevisiae

    Ameeta K. Agarwal;P.David Rogers;Scott R. Baerson;Melissa R. Jacob

  • Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates

    P. David Rogers;Katherine S. Barker

  • Voriconazole: A New Triazole Antifungal Agent

    Margaret M Pearson;P David Rogers;John D Cleary;Stanley W Chapman

  • Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris.

    Jeffrey M. Rybak;José F. Muñoz;Katherine S. Barker;Josie E. Parker

  • An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.

    Clemens J. Heilmann;Sabrina Schneider;Katherine S. Barker;P. David Rogers

  • Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans

    Katherine S. Barker;Sarah Crisp;Nathan P Wiederhold;Russell E. Lewis

  • Genome-wide expression and location analyses of the Candida albicans Tac1p regulon.

    Teresa T. Liu;Sadri Znaidi;Katherine S. Barker;Lijing Xu

  • Regulation of Efflux Pump Expression and Drug Resistance by the Transcription Factors Mrr1, Upc2, and Cap1 in Candida albicans

    Sabrina Schubert;Katherine S. Barker;Sadri Znaidi;Sabrina Schneider

  • Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris.

    Jeffrey M. Rybak;Laura A. Doorley;Andrew T. Nishimoto;Katherine S. Barker

  • Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis

    P. David Rogers;Katherine S. Barker

  • The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris

    Unknown

Frequent Co-Authors

Joachim Morschhäuser
Joachim Morschhäuser University of Würzburg
Nathan P. Wiederhold
Nathan P. Wiederhold The University of Texas Health Science Center at San Antonio
Steven L. Kelly
Steven L. Kelly Swansea University
Brian M. Peters
Brian M. Peters University of Tennessee Health Science Center
Theodore C. White
Theodore C. White University of Missouri–Kansas City
Aaron P. Mitchell
Aaron P. Mitchell University of Georgia
Russell E. Lewis
Russell E. Lewis University of Padua
Scott G. Filler
Scott G. Filler University of California, Los Angeles
Larry S. McDaniel
Larry S. McDaniel University of Mississippi Medical Center
Christina A. Cuomo
Christina A. Cuomo Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to a variety of career paths beyond traditional lab roles. For those seeking alternative options, pursuing online degrees can be especially convenient. Interestingly, some best associate degrees for felons offer flexible entry points into healthcare and science fields, helping individuals overcome employment barriers.

Healthcare roles related to microbiology include becoming a Functional Medicine Nurse Practitioner, a career with growing demand. According to data on functional medicine nurse practitioner salary, this path provides both rewarding patient interaction and competitive compensation.

Another promising direction involves health information management. Professionals in this field manage critical data and ensure compliance with medical regulations. Exploring the health information manager salary reveals it as a lucrative and stable career option.

Additionally, certification as a professional coder offers a specialized niche within healthcare administration. Learning about the cpc certification salary helps highlight the financial benefits and growing career opportunities available in medical coding and billing.

Best Scientists Citing P. David Rogers

Trending Scientists

Recently Published Articles